Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 1198Session 114

Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.

Amendment SA0236

We couldn’t load a readable copy of this version.

Open the official PDF

Official text from the Tennessee Legislature. Formatting has been adapted for reading on Ratifi.